Key points are not available for this paper at this time.
mice. Structural studies confirm that C01 and C04 achieve their blocking effects through Fab-mediated binding to FcγRI. Our data thus suggest that C01 and C04 may offer therapeutic potential for autoimmune disorders.
Holtrop et al. (Wed,) studied this question.